Successful treatment of cancer-associated retinopathy with alemtuzumab

Ladan Espandar; Susan O'Brien; Charles Thirkill; Linda A. Lubecki; Bita Esmaeli

doi:10.1007/s11060-006-9326-7

Successful treatment of cancer-associated retinopathy with alemtuzumab

Ladan Espandar, Susan O'Brien, Charles Thirkill, Linda A. Lubecki, Bita Esmaeli

Research output: Contribution to journal › Article › peer-review

48 Scopus citations

Abstract

We herein report a patient with cancer-associated retinopathy who experienced multiple bouts of paraneoplastic retinopathy and optic neuropathy but responded to treatments with alemtuzumab and was able to maintain useful vision over the course of 8 years of follow-up.

Original language	English (US)
Pages (from-to)	295-302
Number of pages	8
Journal	Journal of neuro-oncology
Volume	83
Issue number	3
DOIs	https://doi.org/10.1007/s11060-006-9326-7
State	Published - Jul 2007

Keywords

Alemtuzumab
Cancer-associated retinopathy
Paraneoplastic syndrome

ASJC Scopus subject areas

Oncology
Neurology
Clinical Neurology
Cancer Research

Access to Document

10.1007/s11060-006-9326-7

Cite this

@article{b0d14a678fd746da86e3b26daaf51af3,

title = "Successful treatment of cancer-associated retinopathy with alemtuzumab",

abstract = "We herein report a patient with cancer-associated retinopathy who experienced multiple bouts of paraneoplastic retinopathy and optic neuropathy but responded to treatments with alemtuzumab and was able to maintain useful vision over the course of 8 years of follow-up.",

keywords = "Alemtuzumab, Cancer-associated retinopathy, Paraneoplastic syndrome",

author = "Ladan Espandar and Susan O'Brien and Charles Thirkill and Lubecki, {Linda A.} and Bita Esmaeli",

year = "2007",

month = jul,

doi = "10.1007/s11060-006-9326-7",

language = "English (US)",

volume = "83",

pages = "295--302",

journal = "Journal of neuro-oncology",

issn = "0167-594X",

publisher = "Kluwer Academic Publishers",

number = "3",

}

TY - JOUR

T1 - Successful treatment of cancer-associated retinopathy with alemtuzumab

AU - Espandar, Ladan

AU - O'Brien, Susan

AU - Thirkill, Charles

AU - Lubecki, Linda A.

AU - Esmaeli, Bita

PY - 2007/7

Y1 - 2007/7

N2 - We herein report a patient with cancer-associated retinopathy who experienced multiple bouts of paraneoplastic retinopathy and optic neuropathy but responded to treatments with alemtuzumab and was able to maintain useful vision over the course of 8 years of follow-up.

AB - We herein report a patient with cancer-associated retinopathy who experienced multiple bouts of paraneoplastic retinopathy and optic neuropathy but responded to treatments with alemtuzumab and was able to maintain useful vision over the course of 8 years of follow-up.

KW - Alemtuzumab

KW - Cancer-associated retinopathy

KW - Paraneoplastic syndrome

UR - http://www.scopus.com/inward/record.url?scp=34250724422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250724422&partnerID=8YFLogxK

U2 - 10.1007/s11060-006-9326-7

DO - 10.1007/s11060-006-9326-7

M3 - Article

C2 - 17252185

AN - SCOPUS:34250724422

SN - 0167-594X

VL - 83

SP - 295

EP - 302

JO - Journal of neuro-oncology

JF - Journal of neuro-oncology

IS - 3

ER -

Successful treatment of cancer-associated retinopathy with alemtuzumab

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this